---

NABP Launching Digital Issue of Innovations

NABP is launching a digital version of its monthly magazine, Innovations , starting with its April 2022 issue. The interactive, mobile-friendly digital version will be accessible via the NABP website. NABP members will also receive a monthly email with a link to access the latest digital Innovations. The digital Innovations is a dynamic and shareable publication and, starting with the summer 2022 issues, will begin to include bonus, digital-only content throughout the year, including:

• Article-based, free continuing pharmacy education;
• Extended article content and related resources;
• Downloadable and shareable infographics;
• Slideshows of meeting photographs; and
• Other interactive visuals.

You will continue to receive the printed version of your complimentary Innovations subscription in the mail, but we hope you will opt in to the digital-only subscription that we will offer later this year. If you have any questions, please the NABP Communications department at commdept@nabp.pharmacy .

---

Live Patient Safety Continuing Education Webinar Hosted by FDA’s Division of Drug Information for Students and Health Care Professionals

The National Association of Boards of Pharmacy (NABP) is pleased to announce that the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Division of Drug Information is presenting a series of live continuing education (CE) webinars designed to aid health care professionals and future clinicians to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. The webinars are presented by FDA staff.

FDA Drug Topics:
FDA Drug Information Resources and Applicability to Health Care Professionals Date: Tuesday, April 26, 2022
Time: 1 PM EDT | 10 AM PDT
Duration: 60 minutes

This webinar will provide an orientation to drug information resources on the FDA website, including drug shortages, drug recalls, adverse event reporting, and product labeling. Additionally, health care professionals will learn how these drug information resources can be used in their practice to locate information that improves patient care.

After signing up for this webinar, registrants will receive a calendar invitation with details on how to join the online meeting. Instructions on how to claim CE credit and obtain a copy of the presentation slides will be emailed to participants the next business day after the webinar.

Please note that the webinar capacity is 1,500 participants; registration does not guarantee entry. Those who are unable to join the meeting may either view the webinar recording that will be posted online or participate in the home study CE course that will be available in a few weeks.

The FDA CDER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

NABP encourages you to forward this information to your staff and to health care professionals in your state. For more information and to learn about future webinars, please visit www.fda.gov/DDIWebinars .